| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |